These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 26559090)
1. Advances in Molecular Biomarkers for Gastric Cancer. Zheng TH; Zhao JL; Guleng B Crit Rev Eukaryot Gene Expr; 2015; 25(4):299-305. PubMed ID: 26559090 [TBL] [Abstract][Full Text] [Related]
2. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer. Yin LK; Sun XQ; Mou DZ Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Liang Y; Wang W; Fang C; Raj SS; Hu WM; Li QW; Zhou ZW Oncotarget; 2016 Aug; 7(31):49565-49573. PubMed ID: 27385101 [TBL] [Abstract][Full Text] [Related]
4. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer. Chen C; Chen Q; Zhao Q; Liu M; Guo J Ann Clin Lab Sci; 2017 May; 47(3):260-263. PubMed ID: 28667025 [TBL] [Abstract][Full Text] [Related]
5. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284 [TBL] [Abstract][Full Text] [Related]
6. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
7. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of Plasma-Methylated Miao J; Liu Y; Zhao G; Liu X; Ma Y; Li H; Li S; Zhu Y; Xiong S; Zheng M; Fei S Cancer Control; 2020; 27(2):1073274820922559. PubMed ID: 32379490 [TBL] [Abstract][Full Text] [Related]
10. An Alternative Method for Screening Gastric Cancer Based on Serum Levels of CEA, CA19-9, and CA72-4. Yu J; Zheng W J Gastrointest Cancer; 2018 Mar; 49(1):57-62. PubMed ID: 28028765 [TBL] [Abstract][Full Text] [Related]
11. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. Yang J; Tang A; Ma J; Sun X; Ming L Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773 [TBL] [Abstract][Full Text] [Related]
12. The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer. Tocchi A; Costa G; Lepre L; Liotta G; Mazzoni G; Cianetti A; Vannini P J Cancer Res Clin Oncol; 1998; 124(8):450-5. PubMed ID: 9750022 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Serum CA72-4 and CEA Levels in Patient with Endoscopically Suspected Gastric Carcinoma. Rehena Z; Ghosh CK; Afroz F; Alam MB; Ferdousi S; Mahmuduzzaman M; Sultana T; Ahmed AN Mymensingh Med J; 2015 Jul; 24(3):542-9. PubMed ID: 26329953 [TBL] [Abstract][Full Text] [Related]
14. The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA. Kodama I; Koufuji K; Kawabata S; Tetsu S; Tsuji Y; Takeda J; Kakegawa T Int Surg; 1995; 80(1):45-8. PubMed ID: 7657491 [TBL] [Abstract][Full Text] [Related]
15. Potential diagnostic and prognostic value of plasma long noncoding RNA LINC00086 and miR-214 expression in gastric cancer. Ji B; Huang Y; Gu T; Zhang L; Li G; Zhang C Cancer Biomark; 2019; 24(2):249-255. PubMed ID: 30689553 [TBL] [Abstract][Full Text] [Related]
16. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory. Hui L; Rixv L; Xiuying Z Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289 [TBL] [Abstract][Full Text] [Related]
17. [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer]. Zhu YB; Ge SH; Zhang LH; Wang XH; Xing XF; DU H; Hu Y; Li YA; Jia YN; Lin Y; Fan B; Ji JF Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):161-4. PubMed ID: 22368025 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902 [TBL] [Abstract][Full Text] [Related]
19. Serum Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) mRNA Protected by Exosomes as a Potential Biomarker for Gastric Cancer. Dong Z; Sun X; Xu J; Han X; Xing Z; Wang D; Ge J; Meng L; Xu X Med Sci Monit; 2019 Oct; 25():7770-7783. PubMed ID: 31619663 [TBL] [Abstract][Full Text] [Related]
20. Plasma activity of Thioredoxin Reductase as a Novel Biomarker in Gastric Cancer. Peng W; Zhou Z; Zhong Y; Sun Y; Wang Y; Zhu Z; Jiao W; Bai M; Sun J; Lu J; Yin H Sci Rep; 2019 Dec; 9(1):19084. PubMed ID: 31836775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]